NASDAQ:INM | Cash Flow Statement | InMed Pharmaceuticals Inc.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$2.97M
2025-12-31-$2.03M
2025-09-30-$1.73M$53,202.00-$1.61M-$137,178.00
2025-06-30-$1.79M$52,752.00-$1.78M$8.17M
2025-03-31-$2.12M
2024-12-31-$2.58M
2024-09-30-$1.68M$54,579.00-$1.83M$838,239.00
2024-06-30-$1.94M$54,767.00-$1.03M$0.00$0.00$176.00
2024-03-31-$1.72M
2023-12-31-$1.48M
2023-09-30-$2.54M$54,832.00-$2.17M
2023-06-30-$338,391.00$53,463.00-$657,934.00-$33,606.00$0.00
2023-03-31-$2M
2022-12-31-$2.1M
2022-09-30-$3.51M$49,048.00-$2.26M$5.43M
2022-06-30-$7.87M$53,988.00-$4.05M$0.00-$725,457.00$5.05M
2022-03-31-$3.48M
2021-12-31-$4.28M
2021-09-30-$2.97M$28,532.00-$2.65M$250,000.00-$250,000.00$10.88M
2021-06-30-$3.26M$28,648.00-$2.01M-$83,176.00
2021-03-31-$3.1M
2020-12-31-$2.24M
2020-09-30-$1.6M$27,981.00-$1.37M-$64,648.00
2020-06-30-$1.62M$26,857.00-$1.4M-$923.00$918.00
2020-03-31-$2.02M
2019-12-31-$2.49M
2019-09-30-$2.81M$30,227.00-$2.37M$32,530.00$3.74M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-06-30-$8.16M$212,839.00-$7.77M$12.27M
2024-06-30-$7.68M$219,600.00-$6.99M$9,293.00-$9,293.00$4.65M
2023-06-30-$7.95M$202,249.00-$7.28M$160,014.00-$661,804.00$10.68M
2022-06-30-$18.6M$185,657.00-$15.58M$39,108.00-$672,999.00$15.07M
2021-06-30-$10.2M$120,866.00-$9.79M$1,725.00-$1,725.00$10.85M
2020-06-30-$8.94M$112,429.00-$7.37M$42,573.00$3.79M-$30,993.00